
Full text loading...
Category: Clinical Microbiology; General Interest
Therapeutic Opportunities in the Vaginal Microbiome, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555819705/9781555819699_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555819705/9781555819699_Chap06-2.gifAbstract:
In order to design and apply a therapeutic, there must be a vaginal disease or disorder in need of treatment or a condition influenced by the vaginal microbiota. There must also be a way for a new therapeutic agent to function through the microbiome. Those conditions include bacterial vaginosis (BV), aerobic vaginitis (AV), urinary tract infection, urethritis, cervicitis, vulvovaginal candidiasis, vulvodynia, endometriosis, and chorioamnitis. In addition, sexually transmitted infections are included, as arguably some may be prevented by vaginal microbes. Cancer is included, not only because of the association with viral infection, but also because microbial dysbiosis has been associated with cancers at other sites.
Full text loading...
Different mechanisms by which beneficial microbes might influence vaginal health.
Different mechanisms by which beneficial microbes might influence vaginal health.
Different mechanisms by which beneficial microbes might influence vaginal health.
Different mechanisms by which beneficial microbes might influence vaginal health.